Freiburg im Breisgau, Germany

Ulrich Birsner

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ulrich Birsner: Innovator in Biological Binding Molecules

Introduction

Ulrich Birsner is a notable inventor based in Freiburg im Breisgau, Germany. He has made significant contributions to the field of biological binding molecules, particularly in the context of cancer diagnostics and therapy. With a total of two patents to his name, Birsner's work is at the forefront of medical innovation.

Latest Patents

Birsner's latest patents focus on diagnostic methods and biological binding molecules. The first patent relates to a diagnostic method that involves the production, identification, and selection of biological binding molecules, such as antibodies. This invention is particularly relevant for diagnosing cancers, specifically malignant B-cell neoplasia. The binding molecules are designed to selectively bind to autonomously active or activated B-cell receptors, which are characterized by specific structural domains.

The second patent also addresses biological binding molecules, emphasizing their use in the therapy and prophylaxis of cancer diseases, including malignant B-cell neoplasia. Similar to the first patent, these binding molecules are capable of selectively binding to B-cell receptors that are autonomously active or activated, highlighting their potential in cancer treatment.

Career Highlights

Throughout his career, Ulrich Birsner has worked with various companies, including Ava Lifescience GmbH. His expertise in the field of biological binding molecules has positioned him as a key player in medical research and innovation.

Collaborations

Birsner has collaborated with notable professionals in his field, including Hassan Jumaa and Holger Klapproth. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Ulrich Birsner's contributions to the field of biological binding molecules and cancer diagnostics are noteworthy. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes. Birsner's work continues to inspire future research in the realm of cancer therapy and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…